WP
PPH icon

WMS Partners’s VanEck Pharmaceutical ETF PPH Stock Holding History

WMS Partners’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,000
Closed -$236K – 276
2023
Q2 		$236K Buy
+3,000
New +$235K 0.02% 252

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

WMS Partners's PPH Position: Q3 2023 in Review

WMS Partners sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2023, closing a stake of 3,000 shares — an estimated $236K sold.

WMS Partners first reported a position in PPH in Q2 2023 and held it in 1 quarter. The position peaked at $236K in Q2 2023. 102 funds tracked by Wall St. Rank hold PPH as of Q3 2023.

  • WMS Partners reported no remaining VanEck Pharmaceutical ETF position as of Q3 2023 after selling out during the quarter.
  • WMS Partners sold 3,000 VanEck Pharmaceutical ETF shares in Q3 2023, an estimated $236K.
  • WMS Partners first reported a position in VanEck Pharmaceutical ETF in Q2 2023 and held it in 1 quarter.
  • WMS Partners's VanEck Pharmaceutical ETF position peaked at $236K in Q2 2023.
  • 102 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2023.

Based on WMS Partners's 13F filing for Q3 2023, filed 9 Nov 2023.